Related Experiment Video
Updated: Jun 30, 2025

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells
Published on: February 21, 2018
miR-26b-5p Affects the Progression of Acute Myeloid Leukemia by Regulating the USP48-Mediated Wnt/β-Catenin Pathway
1Department of Hematology, The First Affiliated Hospital of Kunming Medical University, Kunming 650032, Yunnan, China.
Abstract:
Acute myeloid leukemia (AML) is a highly heterogeneous disease. Exploring the pathogenesis of AML is still an important topic in the treatment of AML. The expression levels of miR-26b-5p and USP48 were measured by qRT-PCR. The expression levels of related proteins were detected by Western blot. Cell proliferation and apoptosis were detected by CCK-8 and flow cytometry, respectively. Coimmunoprecipitation was used to examine the interaction between USP48 and Wnt5a. Bioinformatics analysis showed that high levels of miR-26b-5p and low levels of USP48 were associated with poor prognosis in AML. miR-26b-5p can negatively regulate the expression of USP48. Downregulation of miR-26b-5p inhibited EMT, cell viability and proliferation of AML cells and accelerated apoptosis. Furthermore, the influence of miR-26b-5p inhibition and USP48 knockdown on AML progression could be reversed by a Wnt/β-catenin signaling pathway inhibitor. This study revealed that miR-26b-5p regulates AML progression, possibly by targeting the USP48-mediated Wnt/β-catenin molecular axis to affect AML cell biological behavior.
Insights
MicroRNA-26b-5p (miR-26b-5p) negatively regulates USP48, impacting acute myeloid leukemia (AML) progression. Targeting the miR-26b-5p/USP48 axis offers a potential therapeutic strategy for AML treatment.
Area of Science:
- Hematology
- Molecular Biology
- Oncology
Background:
- Acute myeloid leukemia (AML) is a complex and heterogeneous hematologic malignancy.
- Understanding AML pathogenesis is crucial for developing effective therapeutic strategies.
- The role of specific microRNAs and their target genes in AML progression requires further elucidation.
Purpose of the Study:
- To investigate the functional role of miR-26b-5p and its target USP48 in acute myeloid leukemia (AML).
- To explore the underlying molecular mechanisms, including the Wnt/β-catenin signaling pathway, by which miR-26b-5p affects AML cell behavior.
Main Methods:
- Quantitative real-time PCR (qRT-PCR) and Western blot were used to measure gene and protein expression levels.
- Cell Counting Kit-8 (CCK-8) and flow cytometry assessed cell viability, proliferation, and apoptosis.
- Coimmunoprecipitation examined the interaction between USP48 and Wnt5a.
- Bioinformatics analysis predicted correlations between miR-26b-5p, USP48, and patient prognosis.
Main Results:
- High miR-26b-5p and low USP48 levels correlated with poor prognosis in AML patients.
- miR-26b-5p was found to negatively regulate USP48 expression.
- Downregulation of miR-26b-5p inhibited epithelial-mesenchymal transition (EMT), viability, and proliferation while promoting apoptosis in AML cells.
- USP48 knockdown and miR-26b-5p inhibition effects on AML progression were reversible by a Wnt/β-catenin inhibitor.
Conclusions:
- miR-26b-5p plays a significant role in regulating AML progression.
- The miR-26b-5p/USP48 axis potentially influences AML cell behavior via the Wnt/β-catenin signaling pathway.
- This study highlights miR-26b-5p as a potential therapeutic target for AML.
Related Concept Videos
Abnormal Proliferation
Canonical Wnt Signaling Pathway
Non-Canonical Wnt Signaling Pathways
Master Transcription Regulators
MicroRNAs
mTOR Signaling and Cancer Progression
The mTOR pathway or the...

